Hirsutism future or investigational therapies: Difference between revisions
No edit summary |
|||
| Line 6: | Line 6: | ||
==Overview== | ==Overview== | ||
Fluridil is one of the new [[topical]] treatment options for hirsutism which is not available yet. | |||
==Future or Investigational Therapies== | ==Future or Investigational Therapies== | ||
Fluridil (2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl) phenyl]-3-(2,2,2-trifluoroacetylamino)ropanamide) is a new [[topical]] [[antiandrogen]] agent and has been developed for hyperandrogenic skin syndromes. | Fluridil (2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl) phenyl]-3-(2,2,2-trifluoroacetylamino)ropanamide) is a new [[topical]] [[antiandrogen]] agent and has been developed for hyperandrogenic skin syndromes. | ||
A clinical study has shown that a 2% fluridil gel is a safe and effective treatment method of hirsutism and also has no effect on [[libido]] or sexual function but Fluridil is not available yet.<ref name="pmid12174057">{{cite journal |vauthors=Sovak M, Seligson AL, Kucerova R, Bienova M, Hajduch M, Bucek M |title=Fluridil, a rationally designed topical agent for androgenetic alopecia: first clinical experience |journal=Dermatol Surg |volume=28 |issue=8 |pages=678–85 |year=2002 |pmid=12174057 |doi= |url=}}</ref> | A [[clinical study]] has shown that a 2% fluridil gel is a safe and effective treatment method of hirsutism and also has no effect on [[libido]] or sexual function but Fluridil is not available yet.<ref name="pmid12174057">{{cite journal |vauthors=Sovak M, Seligson AL, Kucerova R, Bienova M, Hajduch M, Bucek M |title=Fluridil, a rationally designed topical agent for androgenetic alopecia: first clinical experience |journal=Dermatol Surg |volume=28 |issue=8 |pages=678–85 |year=2002 |pmid=12174057 |doi= |url=}}</ref> | ||
==References== | ==References== | ||
Revision as of 16:22, 21 September 2017
|
Hirsutism Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Medical Therapy |
|
Case Studies |
|
Hirsutism future or investigational therapies On the Web |
|
Directions to Hospitals Treating Hirsutism future or investigational therapies |
|
Risk calculators and risk factors for Hirsutism future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Rasam Hajiannasab M.D.[2]
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
Fluridil is one of the new topical treatment options for hirsutism which is not available yet.
Future or Investigational Therapies
Fluridil (2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl) phenyl]-3-(2,2,2-trifluoroacetylamino)ropanamide) is a new topical antiandrogen agent and has been developed for hyperandrogenic skin syndromes.
A clinical study has shown that a 2% fluridil gel is a safe and effective treatment method of hirsutism and also has no effect on libido or sexual function but Fluridil is not available yet.[1]